Literature DB >> 11683941

Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases.

C Y Castro1, C A Moran, D G Flieder, S Suster.   

Abstract

AIMS: We describe the clinicopathological characteristics of 15 cases of primary signet ring cell adenocarcinoma of the lung and highlight the importance of recognizing that not all adenocarcinomas with signet ring cell features represent metastatic adenocarcinomas. METHODS AND
RESULTS: We evaluated the clinicopathological and immunohistochemical features of 15 cases of signet ring cell adenocarcinoma of the lung. The patients were 12 men and three women, age 30-75 years (mean 52.5 years). No evidence of a primary tumour elsewhere could be found on thorough clinical examination. Nine patients underwent resection and the remainder were biopsied. The tumours ranged from 18 to 80 mm in greatest dimension. Microscopically, two distinct patterns of growth were recognized: acinar and diffuse. The tumours were characterized by the presence of >75% signet ring cells. Periodic acid-Schiff and mucicarmine showed strong intracellular positive staining. Immunohistochemical stains for TTF-1 (6/6) and CEA (9/9) showed strong positive reaction in all cases evaluated. Three out of six cases were also positive for cytokeratin 7. All the tumours (6/6) were negative for cytokeratin 20, ER, PR and GCDFP-15. Follow-up information was obtained in 11 patients; six patients died within 1 year and five patients were alive from 3 to 36 months after initial diagnosis.
CONCLUSION: These cases highlight an unusual histological growth pattern of primary lung adenocarcinoma that may be mistaken for a metastasis from an occult primary. The recognition of this pattern of lung tumours is important for proper treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683941     DOI: 10.1046/j.1365-2559.2001.01224.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  17 in total

1.  Primary signet-ring cell carcinoma of the lung: a case report with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

3.  Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.

Authors:  Jennifer M Boland; Jason A Wampfler; Jin S Jang; Xiaoke Wang; Michele R Erickson-Johnson; Andre M Oliveira; Ping Yang; Jin Jen; Eunhee S Yi
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

4.  Primary signet ring cell carcinoma of the lung: a rare subtype.

Authors:  Speros Livieratos; James K Smith; Eduard Fatakhov; Christopher F Koch
Journal:  BMJ Case Rep       Date:  2013-09-20

5.  Large Pleural Effusion Secondary to Primary Signet-Ring Cell Adenocarcinoma of the Lung.

Authors:  Sarah Baroud; Sara Moustafa; Halah Ibrahim
Journal:  Cureus       Date:  2021-11-23

6.  Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

Authors:  Scott J Rodig; Mari Mino-Kenudson; Sanja Dacic; Beow Y Yeap; Alice Shaw; Justine A Barletta; Hannah Stubbs; Kenny Law; Neal Lindeman; Eugene Mark; Pasi A Janne; Thomas Lynch; Bruce E Johnson; A John Iafrate; Lucian R Chirieac
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

7.  Primary pure signet-ring cell carcinoma of the extrapulmonary left main bronchus: a case report with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

8.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

9.  Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma.

Authors:  Rita Ötvös; Adam Szulkin; Carl-Olof Hillerdal; Aytekin Celep; Eviane Yousef-Fadhel; Henriette Skribek; Anders Hjerpe; László Székely; Katalin Dobra
Journal:  Genes Cancer       Date:  2015-03

10.  The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.

Authors:  Judit Moldvay; M Jackel; K Bogos; I Soltész; L Agócs; G Kovács; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.